{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:55:28Z","timestamp":1794362128025,"version":"4.9.0"},"reference-count":26,"publisher":"BMJ","issue":"6","funder":[{"name":"American Lebanese and Syrian Associated Charities"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Before 2003, most children with acute lymphoblastic leukaemia (ALL) abandoned treatment, with only approximately 30% treated in China. With the development of national insurance for underprivileged patients, we assessed the current frequency and causes of treatment abandonment among patients with ALL who were enrolled in the Chinese Children\u2019s Cancer Group ALL protocol between 2015 and 2016.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Demographic, clinical and laboratory data on patients who abandoned treatment, as well as economic and sociocultural data of their families were collected and analysed. General health-related statistics were retrieved from publicly accessible databanks maintained by the Chinese government.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At a median follow-up of 119 weeks, 83 (3.1%, 95% CI 2.5% to 3.8%) of the 2641 patients abandoned treatment. Factors independently associated with abandonment included standard\/high-risk ALL (OR 2.62, 95%\u2009CI 1.43 to 4.77), presence of minimal residual disease at the end of remission induction (OR 3.57, 95%\u2009CI 1.90 to 6.74) and low-income economic region (OR 3.7, 95%\u2009CI 1.89 to 7.05). According to the family members, economic constraints (50.6%, p=0.0001) were the main reason for treatment abandonment, followed by the belief of incurability, severe side effects and concern over late complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The rate of ALL treatment abandonment has been greatly reduced in China. Standard\/high-risk ALL, residence in a low-income region and economic difficulties were associated with treatment abandonment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial registration number<\/jats:title>\n                    <jats:p>ChiCTR-IPR-14005706, pre-results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/archdischild-2018-316181","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T17:24:23Z","timestamp":1548955463000},"page":"522-529","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":60,"title":["Treatment abandonment in childhood acute lymphoblastic leukaemia in China: a retrospective cohort study of the Chinese Children\u2019s Cancer Group"],"prefix":"10.1136","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2051-4044","authenticated-orcid":false,"given":"Jiaoyang","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunfu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changda","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjin","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Kong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaili","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul C","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Hon","family":"Pui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,1,31]]},"reference":[{"key":"2021102500301567000_104.6.522.1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.1636"},{"key":"2021102500301567000_104.6.522.2","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S2352-4642(18)30066-X","article-title":"Global efforts toward the cure of childhood acute lymphoblastic leukaemia","volume":"2","author":"Pui","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"2021102500301567000_104.6.522.3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70194-3"},{"key":"2021102500301567000_104.6.522.4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/MPH.0000000000000269","article-title":"Family Refusal of Chemotherapy for Pediatric Cancer Patients: A National Survey of Oncologists","volume":"37","author":"Nassin","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"key":"2021102500301567000_104.6.522.5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3171\/2015.5.PEDS1573","article-title":"Clinical characteristics and abandonment and outcome of treatment in 67 Chinese children with medulloblastoma","volume":"17","author":"Wang","year":"2016","journal-title":"J Neurosurg Pediatr"},{"key":"2021102500301567000_104.6.522.6","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/pbc.25403","article-title":"A practical approach to reporting treatment abandonment in pediatric chronic conditions","volume":"62","author":"Weaver","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"2021102500301567000_104.6.522.7","doi-asserted-by":"crossref","first-page":"e26818","DOI":"10.1002\/pbc.26818","article-title":"Predictors of treatment abandonment for patients with pediatric cancer at Indus Children Cancer Hospital, Karachi, Pakistan","volume":"65","author":"Siddiqui","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"2021102500301567000_104.6.522.8","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/pon.4302","article-title":"Choosing a miracle: Impoverishment, mistrust, and discordant views in abandonment of treatment of children with cancer in El Salvador","volume":"26","author":"Rossell","year":"2017","journal-title":"Psychooncology"},{"key":"2021102500301567000_104.6.522.9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/cncr.31022","article-title":"The cost and cost-effectiveness of childhood cancer treatment in El Salvador, Central America: A report from the Childhood Cancer 2030 Network","volume":"124","author":"Fuentes-Alabi","year":"2018","journal-title":"Cancer"},{"key":"2021102500301567000_104.6.522.10","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-3015"},{"key":"2021102500301567000_104.6.522.11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/08880018.2010.537436","article-title":"Treatment refusal and abandonment in children with acute lymphoblastic leukemia","volume":"28","author":"Wang","year":"2011","journal-title":"Pediatr Hematol Oncol"},{"key":"2021102500301567000_104.6.522.12","doi-asserted-by":"crossref","unstructured":"Li Y , Wu Q , Liu C , et al . Catastrophic health expenditure and rural household impoverishment in China: what role does the new cooperative health insurance scheme play? PLoS One 2014;9:e93253.doi:10.1371\/journal.pone.0093253","DOI":"10.1371\/journal.pone.0093253"},{"key":"2021102500301567000_104.6.522.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0900386"},{"key":"2021102500301567000_104.6.522.14","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22127"},{"key":"2021102500301567000_104.6.522.15","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21127"},{"key":"2021102500301567000_104.6.522.16","doi-asserted-by":"crossref","unstructured":"Kalbfleisch JD , Prentice RL . The Statistical Analysis of Failure Time Data. 2nd Edition. Hoboken, NJ: Wiley-Interscience, 2002:254\u20135.","DOI":"10.1002\/9781118032985"},{"key":"2021102500301567000_104.6.522.17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/02529203.2015.1133432","article-title":"Make Efforts to Develop an Olive-shaped Distribution Pattern: An Analysis Based on Data from the Chinese Social Survey for 2006-2013","volume":"37","author":"Li","year":"2016","journal-title":"Social Sciences in China"},{"key":"2021102500301567000_104.6.522.18","first-page":"106","article-title":"[Incidence trend of malignant tumors in children in Shanghai]","volume":"37","author":"Bao","year":"2016","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"2021102500301567000_104.6.522.19","first-page":"490","article-title":"[Failure of treatment and protocol compliance in patients with acute lymphoblastic leukemia]","volume":"43","author":"Tang","year":"2005","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"2021102500301567000_104.6.522.20","doi-asserted-by":"crossref","unstructured":"Tang S , Tao J , Bekedam H . Controlling cost escalation of healthcare: making universal health coverage sustainable in China. BMC Public Health 2012;12 Suppl 1(Suppl 1):S8.doi:10.1186\/1471-2458-12-S1-S8","DOI":"10.1186\/1471-2458-12-S1-S8"},{"key":"2021102500301567000_104.6.522.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61880-1"},{"key":"2021102500301567000_104.6.522.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60075-1"},{"key":"2021102500301567000_104.6.522.23","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-010-0018-5"},{"key":"2021102500301567000_104.6.522.24","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000000285"},{"key":"2021102500301567000_104.6.522.25","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-1951"},{"key":"2021102500301567000_104.6.522.26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00520-015-2757-y","article-title":"Financial burden of therapy in families with a child with acute lymphoblastic leukemia: report from north India","volume":"24","author":"Ghatak","year":"2016","journal-title":"Support Care Cancer"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2018-316181","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T03:34:04Z","timestamp":1635132844000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2018-316181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,31]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,5,17]]},"published-print":{"date-parts":[[2019,6]]}},"alternative-id":["10.1136\/archdischild-2018-316181"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2018-316181","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,31]]}}}